Soleno Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Soleno Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Soleno Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Soleno Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 158k | 67.60 |
| 2025-06-30 | $8.9M | 106k | 83.78 |
| 2025-03-31 | $4.1M | 58k | 71.45 |
| 2024-12-31 | $2.3M | 50k | 44.95 |
| 2024-09-30 | $2.3M | 45k | 50.49 |
| 2024-06-30 | $1.4M | 34k | 40.80 |
| 2024-03-31 | $2.3M | 54k | 42.80 |
| 2023-12-31 | $716k | 18k | 40.25 |
| 2023-06-30 | $64 | 15 | 4.27 |